173 related articles for article (PubMed ID: 35781038)
1. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
[TBL] [Abstract][Full Text] [Related]
2. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
[TBL] [Abstract][Full Text] [Related]
3. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
[TBL] [Abstract][Full Text] [Related]
4. Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer.
Aiba T; Uehara K; Tsuyuki Y; Ogura A; Murata Y; Mizuno T; Yamaguchi J; Kokuryo T; Yokoyama Y; Ebata T
Eur J Surg Oncol; 2022 Dec; 48(12):2502-2508. PubMed ID: 35768314
[TBL] [Abstract][Full Text] [Related]
5. Variation in outcome measurement and reporting in studies of pelvic exenteration for locally advanced and recurrent rectal cancer: a systematic review.
Brown KGM; Pisaniello J; Ng KS; Solomon MJ; Sutton PA; Hatcher S; Steffens D
Colorectal Dis; 2024 Feb; 26(2):272-280. PubMed ID: 38131647
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer.
Simillis C; Baird DL; Kontovounisios C; Pawa N; Brown G; Rasheed S; Tekkis PP
Ann Surg; 2017 Feb; 265(2):291-299. PubMed ID: 27537531
[TBL] [Abstract][Full Text] [Related]
7. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
8. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
9. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
11. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
[TBL] [Abstract][Full Text] [Related]
12. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.
Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT
Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
PelvEx Collaborative
Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
[TBL] [Abstract][Full Text] [Related]
14. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
15. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
PelvEx Collaborative
Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
[TBL] [Abstract][Full Text] [Related]
16. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
18. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
Palma CA; van Kessel CS; Solomon MJ; Leslie S; Jeffery N; Lee PJ; Austin KKS
Eur J Surg Oncol; 2023 Jul; 49(7):1250-1257. PubMed ID: 36658054
[TBL] [Abstract][Full Text] [Related]
19. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
20. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
